An aging population and high obesity rates continue to increase the prevalence of osteoarthritis and, subsequently, demand for joint replacements. In the next decade Sg2 projects 84 percent growth in hip and knee joint replacement surgery. Despite increasing demand, inpatient (IP) growth will slow substantially due to payer and patient price sensitivity, technology advances, improved pain management efforts and surgeon preference. Outpatient (OP) growth, however, will soar—57 percent of all nonfracture knee and hip replacements will be performed in the OP setting by 2028. Capitalizing on the opportunity will require provider systems to redefine the total joint replacement (TJR) experience via efficient, dedicated ambulatory spaces in both the hospital outpatient department (HOPD) and ASC settings. In short, capturing tremendous TJR opportunity calls for an optimized ambulatory experience.